FDA Hits Tubilux Pharma for Contamination Risks, Particulate Testing

Drug Industry Daily
A A
Drugmaker Tubilux Pharma manufactured products in conditions that risked contamination and failed to properly test its products before release, according to the FDA.

To View This Article:

Login

Subscribe To Drug Industry Daily